LABD ETF

LABD ETF
$8.08
See how much of LABD you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Returns Overview

1 Month
-29.31%
3 Months
-47.89%
6 Months
-62.23%
YTD
-68.65%
1 Year
-88.20%
3 Years (annualized)
-64.52%
5 Years (annualized)
-47.41%
10 Years (annualized)
-58.41%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would LABD have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
PROUpgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
PROUpgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
PROUpgrade to run

1 Month Performance

3 Months Performance

6 Months Performance

1 Year Performance

Benchmark & Peers

Benchmark
S&P Biotechnology Select Industry Index(^SPSIBI:SP)
This ETF (YTD)
-68.65%
Peer Avg (YTD)
+6.77%
vs Peers
-75.42%

LABD ETF Performance

LABD performance across multiple time periods: 1-month -29.31%, YTD -68.65%, 1-year -88.20%, 3-year -64.52%, 5-year -47.41%, 10-year -58.41%.

LABD returns trail the peer average of 6.77% YTD. With an expense ratio of 1.07%, investors should weigh costs against performance when evaluating this ETF.

LABD vs another fund shows side-by-side returns. LABD alternatives are available in the ETF Screener.

Compare LABD

LABD vs SPYLABD vs QQQLABD vs VOOLABD vs VTILABD vs IVVLABD vs SCHDLABD vs VYMLABD vs VXUS

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month-29.31%N/A
3 Months-47.89%N/A
6 Months-62.23%N/A
1 Year-88.20%N/A
3 Years-64.52%N/A
5 Years-47.41%N/A

Periods up to 1 year are total returns; 3, 5 and 10 year figures are annualized